Oxaliplatin (OXA) is a commonly used platinum-based chemotherapy drug for colorectal
cancer. OXA-induced peripheral neurotoxcity (OIPN) is a comprehensive adverse reaction of …

Oxaliplatin (OHP)-induced peripheral neurotoxicity (OIPN) is a severe clinical problem and
potentially permanent side effect of cancer treatment. For the management of OIPN, accurate …

Purpose To determine whether the addition of paclitaxel to doxorubicin plus cisplatin
improves overall survival (OS) in women with advanced or recurrent endometrial carcinoma …

Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a
variety of solid-cancers, substantially improving the five-year survival rates for cancer …

Pharmacological strategies for chemotherapy-induced peripheral neurotoxicity (CIPN) are
very limited. We systematically reviewed data on rehabilitation, exercise, physical therapy …

Our aim was to assess the significance of measuring serum neurofilament light chain (sNfL)
levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity (PIPN). We …

Multiple pathological mechanisms are involved in the development of chemotherapy-
induced peripheral neurotoxicity (CIPN). Recent work has provided insights into the …

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting side effect of
many anti-cancer agents, including taxanes, platinums, vinca alkaloids, proteasome …

Oxaliplatin-based chemotherapy is a standard treatment approach for colorectal cancer
(CRC). However, oxaliplatin-induced peripheral neurotoxicity (OIPN) is a severe dose …

Background Cisplatin-induced peripheral neuropathy (CIPN) is a frequent serious dose-
dependent adverse event that can determine dosage limitations for cancer treatment. CIPN …